UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001416 |
|---|---|
| Receipt number | R000001727 |
| Scientific Title | A multi institutional phase II study of oral fludarabine and rituximab (F-R therapy) for patients with relapsed or refractory mantle cell lymphoma. |
| Date of disclosure of the study information | 2008/10/11 |
| Last modified on | 2013/11/01 11:38:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/10/08 15:38:36 | ||
| 2 | Update | 2011/04/08 09:26:42 | Recruitment status |
|
| 3 | Update | 2011/04/08 09:30:03 | UMIN ID1 |
|
| 4 | Update | 2011/11/30 10:58:49 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2012/04/08 09:16:25 | Last follow-up date |
|
| 6 | Update | 2013/05/11 21:32:21 | Organization Division name Institute |
|
| 7 | Update | 2013/11/01 11:38:44 | Recruitment status |
